Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients

Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients

BackgroundThis study compared the glycemic effectiveness of three metformin-based dual therapies according to baseline hemoglobin A1c (HbA1c) to evaluate the appropriateness of the guideline enforced by the National Health Insurance Corporation of Korea for initial medication of type 2 diabetes (T2D...

Full description

Bibliographic Details
Main Authors: Young Ki Lee, Sun Ok Song, Kwang Joon Kim, Yongin Cho, Younjeong Choi, Yujung Yun, Byung-Wan Lee, Eun-Seok Kang, Bong Soo Cha, Hyun Chul Lee
Format: Article
Language:English
Published: Korean Diabetes Association 2013-12-01
Series:Diabetes & Metabolism Journal
Subjects:
Diabetes mellitus, type 2
Metformin
Pioglitazone
Sitagliptin
Sulphonylurea
Online Access:http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-37-465.pdf

Internet

http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-37-465.pdf

Similar Items